Post

Rita Ehrlich
Ophthalmic research
8y
Animal / preclinicalOphthalmic research · 2018

Retinal Penetration of Intravitreally Injected Tissue Plasminogen Activator: A Rat Model Study.

Kfir Tal, Assaf Dotan, Yael Nisgav … Tami Livnat
Read paper
OphthalmologyAnimal / preclinical

Intravitreal tissue plasminogen activator reached deep retinal layers in all 14 treated rat eyes.

Retinal Penetration of Intravitreally Injected Tissue Plasminogen Activator: A Rat Model Study.

Kfir Tal … Tami Livnat
Ophthalmic research · 2018
Purpose

To determine whether intravitreal unconjugated tissue plasminogen activator (tPA) (alteplase) can penetrate the intact neural retina and reach the subretinal space in an experimental model.

Methods

This study was performed in 24 Sprague-Dawley rats aged 12 weeks.

n = 24 Sprague-Dawley rats
14
Results
14
rats
all treated eyes showed the drug reaching deep layers of the retina
n = 24 Sprague-Dawley rats
More results

In the study group, staining for tPA was detected in the deep retinal layers in all eyes.

The staining was deeper and more intense at 3 and 24 h than at 48 h.

There was no tPA staining in the retina of eyes injected with saline.

“
Conclusion · 1 of 2

This experimental study shows that unconjugated tPA administered into the vitreous is capable of penetrating the deep retinal layers and the subretinal space.

Conclusion · 2 of 2

These findings suggest that further clinical research is warranted on the benefits of intravitreal tPA in the treatment of submacular hemorrhage.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment